Languages Available

Millenium Pharmacon allocates a CapEx of Rp 25 billion

12 April 2019 03:09 PM  Company: PT. Millennium Pharmacon International Tbk[SDPC]
Rp. 106  +2 (1.92%)

JAKARTA - PT Millennium Pharmacon International Tbk (SPDC) allocated Rp25 billion of capital expenditure (CapEx) in 2019, and some of it will be used for technology development.

Mohamad Muhazni Mukhtar, President Director of PT Millenium Pharmacon International Tbk (SDPC), said that the company would focus on investment in technology. "This year, technology pushes companies to achieve efficiency and adequacy," he said.

According to him, Rp 12 billion of the Rp 25 billion will be used for technology development. 

He said that the company would renovate several branches in accordance with BPOM (government) regulations. Furthermore, management also allocates a budget to build a warehouse. (LK/AR)

Related News
PT. Millennium Pharmacon International Tbk [SDPC]   Rp. 106   +2 (1.92%)